Suppression of respiratory burst in human neutrophils by new synthetic pyrrolo-benzylisoquinolines

Biochemical Pharmacology

Volumn 69, Issue 1, 2005, Pages 65-71

  Hwang, Tsong Long ^a   Wu, Yang Chang ^b   Yeh, Shang Hsin ^a   Kuo, Reen Yen ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adenylate cyclase; Cyclic AMP; Neutrophil; Phosphodiesterase; Protein kinase A; Pyrrolo benzylisoquinoline

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 8,9 DIMETHOXYL 1 (3 BROMOPHENYL) 5,6 DIHYDROPYRROLO[2,1 A]ISOQUINOLINE 2,3 DIONE; 8,9 DIMETHOXYL 1 (3 CHLOROPHENYL) 5,6 DIHYDROPYRROLO[2,1 A]ISOQUINOLINE 2,3 DIONE; 8,9 DIMETHOXYL 1 (4 METHOXYPHENYL) 5,6 DIHYDROPYRROLO[2,1 A]ISOQUINOLINE 2,3 DIONE; ADENYLATE CYCLASE; BENZYLISOQUINOLINE DERIVATIVE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GUANYLATE CYCLASE INHIBITOR; ISOBUTYLMETHYLXANTHINE; KT 5823; KW 1; KW 2; KW 3; KW 4; KW 5; KW 6; KW 7; KW 8; KW 9; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE; PHOSPHODIESTERASE IV INHIBITOR; PROTEIN KINASE C INHIBITOR; ROLIPRAM; SUPEROXIDE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

ADOLESCENT; ADULT; BENZYLISOQUINOLINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUTROPHILS; PYRROLES; RESPIRATORY BURST;

EID: 9944238879     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.09.010     Document Type: Article

References (29)

1. N. Borregaard The human neutrophil. Function and dysfunction Eur J Haematol 41 1998 401 413
2. V. Witko-Sarsat, P. Rieu, B. Descamps-Latscha, P. Lesavre, and L. Halbwachs-Mecarelli Neutrophils: molecules, functions and pathophysiological aspects Lab Investig 80 2000 617 653
3. C. Schudt, S. Winder, S. Forderkunz, A. Hatzelmann, and V. Ullrich Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai Naunyn-Schmiedebergs Arch Pharmacol 344 1991 682 690
4. R.G. Coffey Effects of cyclic nucleotides on granulocytes Immunol Ser 57 1992 301 338
5. G.R. Tintinger, A.J. Theron, R. Anderson, and J.A. Ker The anti-inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP-mediated accelerated resequestration of cytosolic calcium Biochem Pharmacol 61 2001 1319 1328
6. Y.M. O'Dowd, J. El-Benna, A. Perianin, and P. Newsholme Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst in human neutrophils by adrenaline: inhibition of phospholipase A2 activity but not p47phox phosphorylation and translocation Biochem Pharmacol 67 2004 183 190
7. D. Denis, and D. Riendeau Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes Eur J Pharmacol 367 1999 343 350
8. J.M. Miotla, M.M. Teixeira, and P.G. Hellewell Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4 Am J Respir Cell Mol Biol 18 1998 411 420
9. D.C. Underwood, S. Bochnowicz, R.R. Osborn, C.J. Kotzer, M.A. Luttmann, and D.W. Hay Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig J Pharmacol Exp Ther 287 1998 988 995
10. H. Kuss, N. Hoefgen, S. Johanssen, T. Kronbach, and C. Rundfeldt In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4- fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration J Pharmacol Exp Ther 307 2003 373 385
11. C.H. Lin, C.M. Yang, C.M. Chen, F.N. Ko, and C.M. Teng Pharmacological characteristics of BDTI, a new isoquinoline-derived beta 2-adrenoceptor agonist, in canine trachea and rat heart Pharmacology 53 1996 19 27
12. S. Weber, B.W. Brandom, D.M. Powers, J.B. Sarner, S.K. Woelfel, and D.R. Cook Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients Anesth Analg 67 1988 495 499
13. S.M. Kupchan, and H.W. Altland Structural requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds J Med Chem 16 1973 913 917
14. K.S. Chen, F.N. Ko, C.M. Teng, and Y.C. Wu Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids J Nat Prod 59 1996 531 534
15. 2+ channels in vascular endothelial cells Life Sci 68 2001 841 847
16. Y.J. Kang, B.K. Lee, Y.S. Lee, H.G. Seo, M.K. Park, and H.J. Kim Suppression of tumor necrosis factor-alpha and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid Biochem Pharmacol 65 2003 457 464
17. R.Y. Kuo, C.C. Wu, F.R. Chang, J.L. Yeh, I.J. Chen, and Y.C. Wu Antiplatelet activity of synthetic pyrrolo-benzylisoquinolines Bioorg Med Chem Lett 13 2003 821 823
18. A. Boyum, D. Lovhaug, L. Tresland, and E.M. Nordlie Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality Scand J Immunol 34 1991 697 712
19. B.M. Babior, R.S. Kipnes, and J.T. Curnutte Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent J Clin Invest 52 1973 741 744
20. A.S. Tan, and M.V. Berridge Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents J Immunol Methods 238 2000 59 68
21. T. Chijiwa, A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, and T. Inoue Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells J Biol Chem 265 1990 5267 5272
22. H. Hidaka, M. Inagaki, S. Kawamoto, and Y. Sasaki Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C Biochemistry 23 1984 5036 5041
23. J. Garthwaite, E. Southam, C.L. Boulton, E.B. Nielsen, K. Schmidt, and B. Mayer Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one Mol Pharmacol 48 1995 184 188
24. C. Dahlgren, and A. Karlsson Respiratory burst in human neutrophils J Immunol Methods 232 1999 3 14
25. J.B. Sedgwick, M.L. Berube, and R.B. Zurier Stimulus-dependent inhibition of superoxide generation by prostaglandins Clin Immunol Immunopathol 34 1985 205 215
26. T.L. Hwang, H.W. Hung, S.H. Kao, C.M. Teng, C.C. Wu, and S.J. Cheng Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway Mol Pharmacol 64 2003 1419 1427
27. K.H. Staubach Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study Arch Surg 133 1998 94 100
28. R. Lauterbach Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial Crit Care Med 27 1999 807 814
29. P.R. Rocco, D.P. Momesso, R.C. Figueira, H.C. Ferreira, R.A. Cadete, and A. Legora-Machado Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury Eur Respir J 22 2003 20 27